Ospedale Ruber Internacional
| Turchia | Austria | Spagna | |
| Ocrevus (ocrelizumab) | da $10,000 | da $35,000 | da $25,000 |
Giorno 1: Arrivo
Giorno 2: Fase pre-operatoria
Giorno 3: Infusione di Ocrevus (ocrelizumab)
Settimana 1-2: Post-operatorio
Settimana 3-4: Riabilitazione
Si prega di notare che l'esperienza di ogni paziente con Ocrevus (ocrelizumab) può variare. Consultare sempre l'equipe medica per un parere personalizzato.
Dr. Jesus Romero Imbroda is a neurologist at Quirónsalud Marbella. He is a Fellow of the European Board of Neurology. Dr. Romero Imbroda serves as an academic at the Royal Academy of Medicine. He focuses on multiple sclerosis research and complex neuromuscular disorders. The doctor also teaches at the University of Granada.
Il dottore è un rinomato neurologo con oltre 40 anni di esperienza e un focus sui disturbi del movimento. Con un contributo significativo ai trattamenti dei disturbi neurodegenerativi, il dottore ha fondato il primo Gruppo specializzato in Disturbi del Movimento della Società Spagnola di Neurologia. Attualmente, il dottore è il Neurologo Capo e Direttore presso l'HM CINAC Integral Neurosciences Centre.<\/p>
Il dottore è stato pioniere nella Stimolazione Dopaminergica Continua per la malattia di Parkinson e nei progressi nella rilevazione delle vulnerabilità dei neuroni dopaminergici. Con una carriera scientifica prolifica, il dottore ha pubblicato oltre 350 articoli di ricerca, principalmente sulla malattia di Parkinson e disturbi correlati.<\/p>
Il medico è un neurologo distinto specializzato in epilessia, attualmente a capo del dipartimento di epilessia presso l'ospedale HM Delfos in Spagna. Con un dottorato di ricerca dall'Università di Bonn e una specializzazione in neurologia dalla Pontificia Universidad Católica de Chile, il medico ha una vasta esperienza nel trattamento dei disturbi neurologici.<\/p>
Come professore all'Università UPF, il medico ha contribuito significativamente al campo attraverso ricerche e pubblicazioni su argomenti come i deficit cognitivi nei pazienti con Alzheimer e l'epilessia resistente ai farmaci. Il medico è attivamente coinvolto in organizzazioni professionali come SEN e la Rete di Riferimento Europea.<\/p>
Prior to Ocrevus infusions, patients must undergo Hepatitis B screening, a vaccination status review, and a pregnancy check. Physicians confirm the absence of active infections and administer mandatory pre-medications, including corticosteroids and antihistamines, to prevent infusion-related reactions. In Spain, JCI-accredited hospitals provide these specialized neuro-immunology services.
Bookimed Expert Insight: While standard Ocrevus infusions take 3.5 hours, high-volume Spanish centers like Hospital HM Nou Delfos offer FAST infusions lasting only 2 hours. This protocol is typically reserved for subsequent doses if the patient showed no reactions during the initial 6-month cycle. Choosing clinics with 75,000+ annual patients ensures the nursing team is highly experienced in managing these specific titration speeds safely.
Patient Consensus: Patients emphasize arriving in comfortable clothing and arranging a driver, as pre-infusion antihistamines often cause significant drowsiness. Many recommend avoiding unmasked crowds for 2 months post-infusion to manage the period of peak immune suppression.
Ocrevus most commonly causes infusion-related reactions such as itchy skin, rash, and throat irritation within 24 hours. Because it suppresses B-cells, patients face a higher risk of upper respiratory infections. Serious risks include progressive multifocal leukoencephalopathy (PML) and potential malignancies like breast cancer.
Bookimed Expert Insight: While clinical data focuses on drug side effects, our records show secondary symptoms often stem from pre-medications. At clinics like Hospital Ruber Internacional or Teknon Medical Center, neurologists use high-dose Benadryl and steroids to prevent allergies. Patients frequently mistake the resulting dizziness or `jelly legs` for the Ocrevus itself.
Patient Consensus: Many report feeling cold during infusions due to IV fluids and suggest bringing blankets. Recovery typically involves 1–2 days of extreme fatigue or migraines before side effects subside.
Ocrevus begins reducing disability progression within 12 weeks of your first infusion. While initial immune system changes occur shortly after treatment, most patients require at least 6 months to observe significant effects in preventing new brain lesions and halting disease activity.
Bookimed Expert Insight: Spain ranks 4th globally for MS treatments on our platform due to high-volume specialist centers. Leading neurologists like Dr. Rafael Arroyo González at Quironsalud Madrid oversee over 100 clinical trials. This high research volume ensures patients receive the most advanced dosing protocols available.
Patient Consensus: Patients emphasize that Ocrevus acts like birth control for MS to prevent new damage. Most recommend taking 2 days off work for each session to manage steroid-induced fatigue.
Ocrevus (ocrelizumab) in Spain is administered as an intravenous infusion in specialized hospital settings. Treatment follows a strict six-month maintenance cycle under the supervision of specialists at JCI-accredited centers in Madrid and Barcelona. Home administration is not currently permitted within the Spanish medical protocol.
Bookimed Expert Insight: While standard infusions take up to 5 hours, experienced patients at top centers like Hospital Universitario HM Madrid can significantly shorten their visit. By opting out of optional pre-medications after successful prior sessions, you can reduce the clinical stay to approximately 2 hours without compromising safety.
Patient Consensus: Patients emphasize planning for a full hospital day and confirm that self-administration is not an option. Many appreciate the streamlined outpatient process where they can walk out immediately after the observation period ends.
Main treatment centers for Ocrevus in Spain are concentrated in Madrid and Barcelona at JCI-accredited facilities like Hospital Ruber Internacional and Centro Médico Teknon. These hubs utilize experienced neurologists and specialized neurosciences centers to manage multiple sclerosis through intravenous monoclonal antibody infusion therapy.
Bookimed Expert Insight: While many patients focus on Madrid or Barcelona, Quirónsalud Marbella offers specialized care under Dr. Jesus Romero Imbroda. As President of the Andalusian Society of Neurology, his expertise provides a high-tier alternative outside the major metropolitan hubs. This is particularly valuable for international patients seeking care in coastal regions without compromising on clinical leadership.
Patient Consensus: Patients emphasize the importance of bringing complete medical records from home to ensure a smooth transition of care. Legal residents typically access treatment through the public system, though private facilities remain the primary choice for international visitors.